Microbiome Diagnostics Market Size is valued at USD 154.9 Mn in 2023 and is predicted to reach USD 488.2 Mn by the year 2031 at a 15.6% CAGR during the forecast period for 2024-2031.
Utilizing advanced genomic and bioinformatic techniques, these diagnostics can profile microbial DNA from samples (e.g., gut, skin, oral cavity) to understand the composition and function of the microbiome. Applications range from disease diagnosis and risk assessment to personalized medicine and predicting drug responses, by identifying specific microbiome signatures associated with certain diseases or health states.
The Microbiome Diagnostics market growth can be attributed to its use of progressive scientific procedures and technologies to inspect the configuration and operation of microbiomes in particular environments, especially within the human body. The microbiome diagnostics market is witnessing steady growth, driven by increasing awareness of the role of microbial communities in health and disease. Advancements in technologies and bioinformatics have enabled more accurate and comprehensive microbiome analysis. However, challenges such as standardization of testing protocols and regulatory hurdles remain, shaping the landscape of this rapidly evolving Market.
The COVID-19 pandemic has positively as well as negatively impacted the microbiome diagnostics market. While there has been increased interest in understanding the pivotal role of the microbiome in immunity and disease susceptibility, disruptions in healthcare systems and reduced research funding have slowed market growth. However, the pandemic has increased the adoption of remote healthcare solutions, leading to a surge in demand for microbiome diagnostics for telemedicine and home testing. Overall, the Market has faced challenges regarding supply chain disruptions and reduced access to healthcare facilities. Still, opportunities have emerged in remote diagnostics and personalized medicine.
The Microbiome Diagnostics Market is segmented by product, Technology, sample, application, end-user, and region. The segmentation based on the products is Reagents & Kits and Instruments. The sample segment comprises Fecal, Saliva, and Skin. Based on application, the segmentation includes Disease Diagnostics Applications, Gastrointestinal Disorders, Metabolic Diseases, and Other Applications. Based on End-User, the segmentation includes Hospitals, Academic and Research Institutes, Biotechnology, and Pharmaceutical Companies.
High consumption of consumables such as kits and reagents and their repeated purchases, along with the increasing number of microbiome diagnostic tests performed across the globe, support the growth of the reagents & kits product segment. The demand for microbiome diagnostics is rising as the instruments play an important role in sanctioning the correct and precise investigation of microbiome samples. Next-generation sequencing apparatus, mass spectrometers, and quantitative PCR gadgets are important in this field. NGS devices are important for sequencing DNA and RNA from microbiome samples, offering comprehensive particulars about the configuration of microbial sections.
The Pharmaceutical and Biotechnologies Segment dominated the Market based on end users. They appear as a sizeable fragment of microbiome diagnostics end users. The microbiome diagnostics market trends include utilizing microbiome data to fabricate inventive remedies, customized medicines, and progressive probiotics. These firms are entrenched in disentangling the complex associations between the human microbiome and varied illnesses. By engaging microbiome diagnostics, they project to distinguish contemporary drug targets, enhance drug efficacy, and lessen the prevalence of unfavourable outcomes.
North America emerges as the most dominant Market due to the region's strong healthcare framework, the notable pervasiveness of gastrointestinal illnesses, and growing consciousness regarding the importance of microbiome balance, which are important elements pushing the assimilation of microbiome diagnostics within the region. North America dominates the microbiome market because of the strong base of healthcare facilities, rising investment from key players, a growing number of processes about drug development, and a rising number of research activities in this region. The joint ventures regarding research between leading economies of this region also boost the market growth. There is an increase in government initiatives to promote awareness, growing research and education activities in the region, a rise in the incidences of lifestyle-related diseases and autoimmune disorders, and a growing demand for quality healthcare.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 154.9 Mn |
|
Revenue Forecast In 2031 |
USD 488.2 Mn |
|
Growth Rate CAGR |
CAGR of 15.6 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Technology, Sample, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Yakult Honsha Co., AOBiome, Enterome Biosciences SA, Metabiomics Corp., Microbiome Therapeutics LLC, Osel, Inc., Rebiotix, Inc., Second Genome, Seres Therapeutics, Synthetic Biologics, Vedanta Biosciences, 4D Pharma, Du Pont De Nemours and Co., Ferring Pharmaceuticals, Genetic Analysis AS, Atlas Biomed, Biome Oxford Ltd., Illumina Inc., Microba Life Sciences, Dna Genotek (Orasure Technologies, Inc.), Viome Life Sciences, Sun Genomics, Becton, Dickinson And Company, Daytwo, OraSure Technologies, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Microbiome Diagnostics Market Snapshot
Chapter 4. Global Microbiome Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Reagents & Kits
5.2.2. Instruments
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
6.2.1. 16S rRNA Sequencing
6.2.2. Shot Gun Metagenomics
6.2.3. Metatranscriptomics
6.2.4. Other Technology
Chapter 7. Market Segmentation 3: by Sample Estimates & Trend Analysis
7.1. by Sample & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Sample:
7.2.1. Feces
7.2.2. Saliva
7.2.3. Skin
7.2.4. Other Sample
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
8.2.1. Disease Diagnostics Application
8.2.1.1. Gastrointestinal Disorders
8.2.1.2. Metabolic Diseases
8.2.1.3. Other Application
8.2.2. Research Application
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
9.2.1. Hospitals
9.2.2. Academic and Research Institutes
9.2.3. Biotechnology and Pharmaceutical Companies
Chapter 10. Microbiome Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Microbiome Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
10.1.2. North America Microbiome Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2019-2031
10.1.3. North America Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.1.4. North America Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.1.5. North America Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.1.6. North America Microbiome Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.2.2. Europe Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.2.3. Europe Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.2.4. Europe Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.2.5. Europe Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.2.6. Europe Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.3.2. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.3.3. Asia-Pacific Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.3.4. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.3.5. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.3.6. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.4.2. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.4.3. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.4.4. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.4.5. Latin America Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.4.6. Latin America Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.5.2. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.5.3. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.5.4. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.5.5. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.5.6. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Yakult Honsha Co.
11.2.2. AOBiome
11.2.3. Enterome Biosciences SA
11.2.4. Metabiomics Corp. (BioSpherex LLC)
11.2.5. Microbiome Therapeutics LLC
11.2.6. Osel, Inc.
11.2.7. Rebiotix, Inc.
11.2.8. Second Genome
11.2.9. Seres Therapeutics
11.2.10. Synthetic Biologics, Inc.
11.2.11. Vedanta Biosciences
11.2.12. 4D Pharma
11.2.13. Du Pont De Nemours and Co.
11.2.14. Ferring Pharmaceuticals
11.2.15. Genetic Analysis AS
11.2.16. Atlas Biomed
11.2.17. Biome Oxford Ltd.
11.2.18. Illumina Inc.
11.2.19. Microba Life Sciences
11.2.20. Dna Genotek (Orasure Technologies, Inc.)
11.2.21. Viome Life Sciences
11.2.22. Sun Genomics
11.2.23. Becton, Dickinson And Company
11.2.24. Daytwo
11.2.25. OraSure Technologies, Inc.
11.2.26. Other Prominent Players
Microbiome Diagnostics Market By Product-
Microbiome Diagnostics Market By Technology-
Microbiome Diagnostics Market By Sample-
Microbiome Diagnostics Market By Application-
Microbiome Diagnostics Market By End-User-
Microbiome Diagnostics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
